$CRTG
CORETEC GROUP INC.

2015 Q4 Form 10-Q Financial Statement

#000114420415065745 Filed on November 16, 2015

View on sec.gov

Income Statement

Concept 2015 Q4 2015 Q3 2014 Q4
Revenue $0.00 $0.00 $20.00K
YoY Change -100.0% -100.0% -60.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $170.0K $60.00K $210.0K
YoY Change -19.05% -73.91% -22.22%
% of Gross Profit
Research & Development $0.00 $520.00 $60.00K
YoY Change -100.0% -98.93% -33.33%
% of Gross Profit
Depreciation & Amortization $0.00
YoY Change
% of Gross Profit
Operating Expenses $170.0K $520.00 $270.0K
YoY Change -37.04% -98.93% -25.0%
Operating Profit
YoY Change
Interest Expense $0.00 $5.252K -$20.00K
YoY Change -100.0% -49.92% 0.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$170.0K -$60.00K -$270.0K
YoY Change -37.04% -79.31% -18.18%
Income Tax
% Of Pretax Income
Net Earnings -$170.0K -$61.58K -$270.0K
YoY Change -37.04% -78.6% -18.18%
Net Earnings / Revenue -1350.0%
Basic Earnings Per Share
Diluted Earnings Per Share -$40.67K -$12.17K -$156.1K
COMMON SHARES
Basic Shares Outstanding 1.231B shares 893.7M shares 528.2M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q4 2015 Q3 2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.00K $0.00 $30.00K
YoY Change -66.67% -100.0% -57.14%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $0.00 $30.00K $20.00K
YoY Change -100.0% 0.0% 100.0%
Inventory
Prepaid Expenses $1.825K $30.14K $17.15K
Receivables
Other Receivables
Total Short-Term Assets $15.64K $33.96K $51.63K
YoY Change -69.72% -63.88% -39.03%
LONG-TERM ASSETS
Property, Plant & Equipment $7.247K
YoY Change
Goodwill $0.00
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $10.00K $10.00K
YoY Change -100.0% 0.0% -66.67%
Total Long-Term Assets $19.12K $5.982K $5.440K
YoY Change 251.49% 0.08% -80.41%
TOTAL ASSETS
Total Short-Term Assets $15.64K $33.96K $51.63K
Total Long-Term Assets $19.12K $5.982K $5.440K
Total Assets $34.76K $39.94K $57.07K
YoY Change -39.1% -60.06% -49.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $24.52K $628.1K $384.6K
YoY Change -93.63% 132.62% 173.94%
Accrued Expenses $0.00 $320.0K $190.0K
YoY Change -100.0% 113.33% 850.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due -$183.4K $300.0K $410.0K
YoY Change -144.73% -41.18% -32.79%
Total Short-Term Liabilities $27.56K $1.250M $1.007M
YoY Change -97.26% 34.44% 4.53%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00
YoY Change -100.0%
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $27.56K $1.250M $1.007M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $158.1K $1.250M $1.007M
YoY Change -84.29% 34.38% 4.53%
SHAREHOLDERS EQUITY
Retained Earnings -$135.3K -$21.99M -$21.26M
YoY Change -99.36%
Common Stock -$952.00 $20.78M $20.31M
YoY Change -100.0% 5.63% 8.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$135.3K -$1.210M -$949.8K
YoY Change
Total Liabilities & Shareholders Equity $22.88K $39.94K $57.07K
YoY Change -59.91% -60.34% -49.25%

Cashflow Statement

Concept 2015 Q4 2015 Q3 2014 Q4
OPERATING ACTIVITIES
Net Income -$170.0K -$61.58K -$270.0K
YoY Change -37.04% -78.6% -18.18%
Depreciation, Depletion And Amortization $0.00
YoY Change
Cash From Operating Activities $70.00K -$30.00K -$80.00K
YoY Change -187.5% -88.0% -68.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -60.00K 30.00K 40.00K
YoY Change -250.0% -90.32% -87.1%
NET CHANGE
Cash From Operating Activities 70.00K -30.00K -80.00K
Cash From Investing Activities
Cash From Financing Activities -60.00K 30.00K 40.00K
Net Change In Cash 10.00K 0.000 -40.00K
YoY Change -125.0% -100.0% -166.67%
FREE CASH FLOW
Cash From Operating Activities $70.00K -$30.00K -$80.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
141959 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
850779 USD
CY2014Q4 us-gaap Cash
Cash
34485 USD
CY2015Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
30136 USD
CY2014Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
17149 USD
CY2015Q3 us-gaap Assets Current
AssetsCurrent
33957 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
51634 USD
us-gaap Net Income Loss
NetIncomeLoss
-984667 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.001
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
352697553 shares
CY2015Q3 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
3667 USD
CY2014Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
3125 USD
CY2015Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
2315 USD
CY2014Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
2315 USD
CY2015Q3 us-gaap Assets
Assets
39939 USD
CY2015Q3 us-gaap Cash
Cash
3821 USD
us-gaap Interest Expense
InterestExpense
53677 USD
us-gaap Interest Expense
InterestExpense
58656 USD
CY2014Q4 us-gaap Assets
Assets
57074 USD
CY2015Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
299349 USD
CY2014Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
405791 USD
CY2015Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
56 USD
CY2014Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
21591 USD
CY2015Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
628087 USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
384639 USD
CY2015Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
273865 USD
CY2014Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
158102 USD
CY2015Q3 us-gaap Interest Payable Current
InterestPayableCurrent
48952 USD
CY2014Q4 us-gaap Interest Payable Current
InterestPayableCurrent
36777 USD
CY2015Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1250309 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1006900 USD
CY2015Q3 us-gaap Liabilities
Liabilities
1250309 USD
CY2014Q4 us-gaap Liabilities
Liabilities
1006900 USD
CY2015Q3 us-gaap Preferred Stock Value
PreferredStockValue
71 USD
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
71 USD
CY2015Q3 us-gaap Common Stock Value
CommonStockValue
208498 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
107935 USD
CY2015Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
20573346 USD
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
20200743 USD
CY2015Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-21992285 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-21258575 USD
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
-1210370 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-949826 USD
CY2015Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
39939 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
57074 USD
CY2014Q3 us-gaap Sales Revenue Net
SalesRevenueNet
5000 USD
CY2015Q3 us-gaap Sales Revenue Net
SalesRevenueNet
0 USD
CY2014Q3 us-gaap Revenue From Grants
RevenueFromGrants
0 USD
CY2015Q3 us-gaap Revenue From Grants
RevenueFromGrants
0 USD
CY2014Q3 us-gaap Revenues
Revenues
5000 USD
CY2015Q3 us-gaap Revenues
Revenues
0 USD
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
48428 USD
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
520 USD
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
233841 USD
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
161936 USD
CY2014Q3 us-gaap Interest Expense
InterestExpense
10488 USD
CY2015Q3 us-gaap Interest Expense
InterestExpense
32907 USD
CY2014Q3 us-gaap Costs And Expenses
CostsAndExpenses
292757 USD
CY2015Q3 us-gaap Costs And Expenses
CostsAndExpenses
195363 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-287757 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-195363 USD
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.001
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.000
CY2014Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
413267018 shares
CY2015Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
908180141 shares
us-gaap Sales Revenue Net
SalesRevenueNet
15000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
0 USD
us-gaap Revenue From Grants
RevenueFromGrants
46748 USD
us-gaap Revenue From Grants
RevenueFromGrants
5122 USD
us-gaap Revenues
Revenues
61748 USD
us-gaap Revenues
Revenues
5122 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
45758 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
634418 USD
us-gaap Costs And Expenses
CostsAndExpenses
1046415 USD
us-gaap Costs And Expenses
CostsAndExpenses
738832 USD
us-gaap Net Income Loss
NetIncomeLoss
-733710 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.003
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
762022810 shares
tdcp Stock Issued During Period Value Stock Options And Warrants Exercised
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
76245 USD
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
261920 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
108500 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
60001 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
66648 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
33171 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
14255 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
12987 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
249724 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
446386 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-574050 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-207139 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
464310 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
54710 USD
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
220500 USD
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
121765 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
115680 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
569130 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
176475 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-4920 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-30664 USD
CY2013Q4 us-gaap Cash
Cash
70769 USD
CY2014Q3 us-gaap Cash
Cash
65849 USD
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
256062 USD
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
261921 USD
us-gaap Interest Paid
InterestPaid
2625 USD
us-gaap Interest Paid
InterestPaid
1004 USD
us-gaap Stock Issued1
StockIssued1
-8734 USD
us-gaap Stock Issued1
StockIssued1
75000 USD
us-gaap Net Income Loss
NetIncomeLoss
21992285 USD
CY2015Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0475 pure
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
54710 USD
CY2015Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
299349 USD
CY2014Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
405791 USD
CY2014Q1 tdcp Purchase Price Per Share
PurchasePricePerShare
1.00
CY2014Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
385000 USD
CY2014Q1 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
190000 shares
CY2013Q4 us-gaap Payments For Repurchase Of Private Placement
PaymentsForRepurchaseOfPrivatePlacement
195000 USD
CY2013Q4 us-gaap Payments For Repurchase Of Private Placement
PaymentsForRepurchaseOfPrivatePlacement
195000 USD
CY2013Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
195000 USD
tdcp Conversion Price Of Stock
ConversionPriceOfStock
0.05
CY2014Q3 tdcp Conversion Rate To Closing Bid Price
ConversionRateToClosingBidPrice
0.65 pure
CY2015Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0002
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0002
CY2015Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2015Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
355000 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
355000 shares
CY2015Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
355000 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
355000 shares
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0002
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0002
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000 shares
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1042491151 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
539674567 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
539674567 shares
us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><i><font style="FONT-SIZE: 10pt">Use of Estimates</font></i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and the disclosure of contingent assets and liabilities. Actual results could differ from the estimates and assumptions used.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013Q3 us-gaap Grants Receivable
GrantsReceivable
300000 USD
CY2014Q1 tdcp Warrants To Purchase Of Common Stock
WarrantsToPurchaseOfCommonStock
50 shares
us-gaap Lease Expiration Date1
LeaseExpirationDate1
2018-07-31
CY2015Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
67000 USD
CY2015Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
6000 USD
CY2015Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
23000 USD
CY2015Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
24000 USD
CY2015Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
14000 USD
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2015-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Registrant Name
EntityRegistrantName
3DICON CORP
dei Entity Central Index Key
EntityCentralIndexKey
0001375195
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Trading Symbol
TradingSymbol
TDCP
CY2015Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1230991151 shares
tdcp Conversion Closing Bid Price
ConversionClosingBidPrice
0.01

Files In Submission

Name View Source Status
0001144204-15-065745-index-headers.html Edgar Link pending
0001144204-15-065745-index.html Edgar Link pending
0001144204-15-065745.txt Edgar Link pending
0001144204-15-065745-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tdcp-20150930.xml Edgar Link completed
tdcp-20150930.xsd Edgar Link pending
tdcp-20150930_cal.xml Edgar Link unprocessable
tdcp-20150930_def.xml Edgar Link unprocessable
tdcp-20150930_lab.xml Edgar Link unprocessable
tdcp-20150930_pre.xml Edgar Link unprocessable
v423684_10q.htm Edgar Link pending
v423684_ex31-1.htm Edgar Link pending
v423684_ex31-2.htm Edgar Link pending
v423684_ex32-1.htm Edgar Link pending
v423684_ex32-2.htm Edgar Link pending